What is the ROE (Return on Equity) of Zynex this year?
The ROE of Zynex this year is 0.08 undefined.
Zynex ROE 2025
Zynex ROE
0.08
Ticker
ZYXI
ISIN
US98986M1036
WKN
A0Q5XP
In 2025, Zynex's return on equity (ROE) was 0.08, a -60.26% increase from the 0.21 ROE in the previous year.
Zynex Aktienanalyse
What does Zynex do?
Zynex Inc is an American company that manufactures and distributes medical devices and accessories. The company was founded in 1996 and is headquartered in Englewood, Colorado. In recent years, it has become a major player in the pain therapy market. The history of Zynex began with the development of a neurotherapeutic system called NeuroMove, which aimed to restore mobility in patients with paralysis after strokes or other neurological disorders. The company uses proprietary technology to provide safe and effective electrotherapeutic stimulation, which helps trigger muscle contractions and improve mobility. Over the years, the company has specialized in the development and sale of medical devices for pain therapy and rehabilitation. Zynex's products can be used in various areas, including electrostimulation, TENS and EMS therapy, home diagnostics, as well as blood pressure and oxygen measurement. Zynex offers devices specifically for pain therapy. These devices are used by many doctors and physiotherapists to support patients in their healing process. The company's flagship product is the Nexus D-11 EMS and TENS device, which is capable of conducting multiple pain treatments simultaneously. Another important device from Zynex is the InWave system, which applies FDA-approved electromagnetic wave therapy. The therapy is used for both acute and chronic pain and aims to promote the body's natural healing processes to relieve pain. Zynex also manufactures home diagnostic devices such as the blood sugar monitor and pulse oximeter, which can be regularly used by patients at home to monitor their well-being. These products help individuals develop an understanding of how their body responds to different treatments or environmental conditions. An important aspect of Zynex's business model is collaborating with healthcare customers. The company forms partnerships with medical facilities and practitioners to ensure that its products are effectively and safely utilized. These partnerships often include training programs to ensure that users of each device develop a basic understanding of how it works to ensure quality treatment. Zynex has also established a subsidiary called Zynex Medical Europe, which operates in European regions. The company is based in the Netherlands and is responsible for marketing and distributing Zynex's products in Europe. Overall, Zynex has established itself as a key player in the field of pain therapy and rehabilitation. Through its innovative technology and healthcare partnerships, the company is able to provide the best possible patient care. Zynex ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding Zynex's Return on Equity (ROE)
Zynex's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing Zynex's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
Zynex's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in Zynex’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about Zynex stock
How has the Return on Equity (ROE) of Zynex developed compared to the previous year?
The ROE of Zynex has increased by -60.26% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of Zynex?
A high ROE indicates that Zynex generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of Zynex?
A low ROE can indicate that Zynex is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of Zynex affect the company?
A change in ROE (Return on Equity) of Zynex can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of Zynex?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of Zynex?
Some factors that can influence Zynex's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does Zynex pay?
Over the past 12 months, Zynex paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Zynex is expected to pay a dividend of -0.11 USD.
What is the dividend yield of Zynex?
The current dividend yield of Zynex is .
When does Zynex pay dividends?
Zynex pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Zynex?
Zynex paid dividends every year for the past 1 years.
What is the dividend of Zynex?
For the upcoming 12 months, dividends amounting to -0.11 USD are expected. This corresponds to a dividend yield of -7.25 %.
In which sector is Zynex located?
Zynex is assigned to the 'Health' sector.
Wann musste ich die Aktien von Zynex kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Zynex from 1/21/2022 amounting to 0.1 USD, you needed to have the stock in your portfolio before the ex-date on 1/5/2022.
When did Zynex pay the last dividend?
The last dividend was paid out on 1/21/2022.
What was the dividend of Zynex in the year 2024?
In the year 2024, Zynex distributed 0 USD as dividends.
In which currency does Zynex pay out the dividend?
The dividends of Zynex are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Zynex
Our stock analysis for Zynex Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zynex Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
